C
Clarity Pharmaceuticals Ltd
ASX:CU6
Clarity Pharmaceuticals Ltd
ASX:CU6
Price:
3.41
AUD
-4.75%
Market Closed
Market Cap:
AU$1.3B
Relative Value
The Relative Value of one CU6 stock under the Base Case scenario is hidden AUD. Compared to the current market price of 3.41 AUD, Clarity Pharmaceuticals Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CU6 Relative Value
HIDDEN
Multiples Across Competitors
CU6 Competitors Multiples
Clarity Pharmaceuticals Ltd Competitors
Clarity Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
1.3B AUD | 0 | -19.7 | -17.1 | -17.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
982.7B USD | 15.1 | 47.6 | 32.1 | 34.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.1B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
292.8B CHF | 4.8 | 31.1 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
240.1B GBP | 5.6 | 32.1 | 17.7 | 24.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
247.3B CHF | 5.6 | 22.7 | 14 | 17.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302.6B USD | 4.7 | 16.6 | 10.3 | 12.1 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.4 | 9.8 | 11.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.1B USD | 2.5 | 20.1 | 7.5 | 10 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
91B GBP | 2.8 | 16 | 8 | 11.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
